Stanislav Engel

Title: Stanislav Engel: Innovator in Antibody Research

Introduction

Stanislav Engel is a prominent inventor based in Beer Sheva, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 3 patents to his name, Engel's work focuses on innovative solutions for serious medical conditions.

Latest Patents

Engel's latest patents include groundbreaking inventions such as "Anti superoxide dismutase 1 (SOD1) antibodies and use thereof." This invention is directed to an antibody or an antigen-binding portion thereof that has a specific binding affinity to a misfolded SOD1. The patent also covers pharmaceutical compositions comprising the antibody and methods of using it. Another notable patent is for "Isolated polypeptide and compositions comprising same," which provides a composition and method for treating, delaying the onset, and reducing the severity of amyotrophic lateral sclerosis in a subject. This composition includes a peptide derived from SOD1, which can inhibit the formation of SOD1 amyloid-like aggregates or be used for the production of anti-SOD1 antibodies.

Career Highlights

Throughout his career, Engel has been associated with reputable institutions, including the Ben-Gurion University of the Negev Research and Development Authority and B.G. Negev Technologies and Applications Ltd. His work has significantly advanced the understanding and treatment of neurodegenerative diseases.

Collaborations

Engel has collaborated with notable colleagues such as David M. Chipman and Ze'ev Barak, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Stanislav Engel's contributions to antibody research and biotechnology are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.